Concepedia

Mary Scott Roberts

MS

14

Publications

675

Citations

14

H-Index

1994

Active since

Affiliations

Ultragenyx Pharmaceutical (United States)(Current)

Indiana University – Purdue University Indianapolis

Indiana University School of Medicine

University of California, San Francisco

Royal Manchester Children's Hospital

Mary Scott Roberts is an author at Ultragenyx Pharmaceutical (United States) specializing in medicine, urology, and osteoporosis.

ORCID

Top concepts

Publications per year

1994–2024

14

Publications

14

Burosumab for the Treatment of Tumor-Induced Osteomalacia

Suzanne M. Jan de Beur, Paul D. Miller, Thomas J. Weber et al. · Journal of Bone and Mineral Research · 2020 · 167 citations · Full text

Prospective phenotyping of long-term survivors of generalized arterial calcification of infancy (GACI)

Carlos R. Ferreira, Mary E. Hackbarth, Shira G. Ziegler et al. · Genetics in Medicine · 2020 · 82 citations · Full text

, , +9

Sustained Efficacy and Safety of Burosumab, a Monoclonal Antibody to FGF23, in Children With X-Linked Hypophosphatemia

Agnès Linglart, Erik A. Imel, Michael P. Whyte et al. · The Journal of Clinical Endocrinology & Metabolism · 2021 · 80 citations · Full text

Effect of Burosumab Compared With Conventional Therapy on Younger vs Older Children With X-linked Hypophosphatemia

Leanne M. Ward, Francis H. Glorieux, Michael P. Whyte et al. · The Journal of Clinical Endocrinology & Metabolism · 2022 · 69 citations · Full text

Diagnosis and Management of Tumor-induced Osteomalacia: Perspectives From Clinical Experience

Kathryn Dahir, María Belén Zanchetta, Irinel Stanciu et al. · Journal of the Endocrine Society · 2021 · 56 citations · Full text

Rows per page

1–5 of 14